- D-Wave Quantum Inc. recently completed a finance leadership transition, with senior vice president of finance Greg Golkov becoming acting Chief Financial Officer and principal financial and accounting officer following the retirement of long-time CFO John Markovich on September 2, 2026.
- Markovich’s departure, which the company says did not stem from disagreements over financial reporting or controls, comes as D-Wave faces weaker-than-expected revenue and new legal investigations, keeping attention firmly on its governance and financial oversight.
- We’ll now examine how the CFO transition and related governance concerns may affect D-Wave Quantum’s previously outlined investment narrative.
AI is about to change healthcare. These 37 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.
D-Wave Quantum Investment Narrative Recap
To own D-Wave Quantum, you have to believe its annealing and emerging gate model platforms can convert proofs of concept into larger, recurring QCaaS and system deals while it manages heavy losses and cash needs. Right now, the key near term catalyst is whether larger enterprise and government workloads scale, and the biggest risk is continued operating losses and legal scrutiny. The latest CFO transition appears more about continuity than a material shift in those drivers.
The most relevant backdrop to this finance leadership change is D-Wave’s recent Q2 2026 results, with US$3.08 million in revenue against a US$48.03 million net loss. Those numbers highlight why investors are focused on governance, controls and capital discipline as Golkov steps in. His prior responsibility for SEC reporting and financial planning suggests the board is emphasizing stability in how the company reports, funds and measures progress on the same commercialization milestones investors are watching.
Yet, while headline partnerships and technical milestones attract attention, investors should also be aware of the growing legal investigations and what they could mean for…
Read the full narrative on D-Wave Quantum (it’s free!)
D-Wave Quantum’s narrative projects $201.1 million revenue and $23.0 million earnings by 2029. This requires 152.9% yearly revenue growth and an earnings increase of about $272 million from -$248.7 million today.
Uncover how D-Wave Quantum’s forecasts yield a $35.24 fair value, a 113% upside to its current price.
Exploring Other Perspectives
The most bearish analysts were already assuming rapid revenue growth of about 123 percent a year but still no profits, which is far more pessimistic than narratives that highlight faster government and enterprise adoption, and this new CFO transition could shift how you weigh those very different views.
Explore 13 other fair value estimates on D-Wave Quantum – why the stock might be worth over 7x more than the current price!
Form Your Own Verdict
Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.
- A great starting point for your D-Wave Quantum research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
- Our free D-Wave Quantum research report provides a comprehensive fundamental analysis summarized in a single visual – the Snowflake – making it easy to evaluate D-Wave Quantum’s overall financial health at a glance.
Looking For Alternative Opportunities?
Markets shift fast. These stocks won’t stay hidden for long. Get the list while it matters:
- Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
- Outshine the giants: these 19 early-stage AI stocks could fund your retirement.
- The latest GPUs need a type of rare earth metal called Dysprosium and there are only 31 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New:Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks
Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com
You can copy Bill Ackman and buy Netflix. Knowing why you did is the hard part.
Netflix case is interesting. The scariest competitor is the one that does not need to make money. Amazon can run video at a loss forever because it is really a Prime retention tool with a content budget attached. On the other hand there is Youtube.
Pershing Square hasn’t beaten the S&P over the last five years, though the long-run record is genuinely good. I like Ackman as a person. I enjoy listening to Ackman and that’s about where it ends for me.
Mitchell Lawler
Market Insights
What 13F filings won’t tell you about a billionaire’s stock picks
Fresh 13F filings are where some investors go to find their next stock pick. The problem is it’s missing some of the most important details for making a good investment.
30
Sep 4, 2026
About NasdaqGS:QBTS
D-Wave Quantum
Engages in the development and delivery of quantum computing systems, software, and services worldwide.
Flawless balance sheet with low risk.
Similar Companies
Market Insights
What 13F filings won’t tell you about a billionaire’s stock picksMI
Mitchell Lawler
Great earnings season, but are the earnings real?AN
Andrew Legget
Which payment stocks actually get paid?MI
Mitchell Lawler
Advertisement
Weekly Picks
Lou_Baseneseon Oncolytics Biotech·18 days ago
The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech
Fair Value:US$3.575.9% undervalued
67followersusers have followed this narrative
·1commentusers have commented on this narrative
·17likesusers have liked this narrative
AN
andrei9868on ServiceNow·22 days ago
The Platform Turning Enterprise Chaos into Autonomous Workflows
John_Ericon Vistra·6 days ago
Vistra Fell 38%. Adjusted EBITDA Rose 31%. Here’s the $472 Million Reason They Disagree.
HarishPKon EverQuote·16 days ago
EverQuote and an Asymmetric Investment Opportunity
RecentlyUpdated Narratives
RogueEPon Quanex Building Products·about 2 hours ago
The Market Is Pricing a Housing Cyclical. We See a Self-Funding Consolidator
Fair Value:US$33.3331.2% undervalued
1followerusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
JO
John_Ericon Hamilton Lane·about 3 hours ago
Analysts Cut Their Targets. The Co-Chairman Cut a Check.
John_Ericon Cigna Group·about 3 hours ago
We Underwrote the Underwriter
Popular Narratives
oscargarciaon NVIDIA·3 months ago
The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
John_Ericon MercadoLibre·1 day ago
MercadoLibre and the Spreadsheet Trick That Decides Everything
Fair Value:US$3.68k46.2% undervalued
129followersusers have followed this narrative
·3commentsusers have commented on this narrative
·18likesusers have liked this narrative
ANAnalystConsensusTargeton NVIDIA·about 1 month ago
